Spire Health Closed A $38M Financing Round To Expand Commercialization Of Respiratory Remote Patient Monitoring Platform
Spire Health plans to use its new financing to expand commercialization of its respiratory remote patient monitoring platform, which combines AI with sensors in “health tags” worn inside clothing.
You may also be interested in...
In this roundup feature focusing on the developments in digital health, we highlight the key news and announcements from July.
The inhalation devices market will reach $12bn by 2023, driven by the rising prevalence of asthma and COPD worldwide. GlaxoSmithKline, AstraZeneca and Boehringer Ingelheim dominate worldwide sales of inhalation products for asthma and COPD, and are facing generic competition. Generics developers and major pharma players are trying to set themselves apart with better drug-delivery devices.
Dexcom is making CGM data available through consumer devices starting with Garmin’s smartwatches and bicycle computers.